BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24719252)

  • 1. Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms.
    Tu H; Ahearn TU; Daniel CR; Gonzalez-Feliciano AG; Seabrook ME; Bostick RM
    Mol Carcinog; 2015 Sep; 54(9):821-30. PubMed ID: 24719252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.
    Kwan AK; Um CY; Rutherford RE; Seabrook ME; Barry EL; Fedirko V; Baron JA; Bostick RM
    Mol Carcinog; 2019 Apr; 58(4):511-523. PubMed ID: 30499618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial.
    Tu H; Flanders WD; Ahearn TU; Daniel CR; Gonzalez-Feliciano AG; Long Q; Rutherford RE; Bostick RM
    Mol Carcinog; 2015 Apr; 54(4):270-80. PubMed ID: 24166893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.
    Ahearn TU; Shaukat A; Flanders WD; Seabrook ME; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):969-79. PubMed ID: 22539608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Cohen VL; Dash C; Seabrook ME; Fedirko V
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1599-609. PubMed ID: 19423536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas.
    Yang B; Thyagarajan B; Gross MD; Goodman M; Sun YV; Bostick RM
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E187-92. PubMed ID: 23776012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.
    Daniel CR; Bostick RM; Flanders WD; Long Q; Fedirko V; Sidelnikov E; Seabrook ME
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):65-73. PubMed ID: 19124482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.
    Liu S; Barry EL; Baron JA; Rutherford RE; Seabrook ME; Bostick RM
    Mol Carcinog; 2017 Feb; 56(2):412-424. PubMed ID: 27254743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue localization of TGFalpha and apoptosis are inversely related in colorectal tumors.
    Habel O; Bertario L; Andreola S; Sirizzotti G; Marian B
    Histochem Cell Biol; 2002 Mar; 117(3):235-41. PubMed ID: 11914921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue.
    Pannain VL; Morais JR; Damasceno-Ribeiro O; Avancini-Alves V
    Ann Hepatol; 2012; 11(4):495-9. PubMed ID: 22700631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose.
    Hardman WE; Cameron IL; Beer WH; Speeg KV; Kadakia SC; Lang KA
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):633-7. PubMed ID: 9264277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of precursor transforming growth factor beta1 in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjo A
    Int J Mol Med; 2001 Jun; 7(6):597-601. PubMed ID: 11351271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
    Furuse C; Miguita L; Rosa AC; Soares AB; Martinez EF; Altemani A; de Araújo VC
    J Oral Pathol Med; 2010 Aug; 39(7):540-7. PubMed ID: 20149060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.
    Berndt SI; Huang WY; Chatterjee N; Yeager M; Welch R; Chanock SJ; Weissfeld JL; Schoen RE; Hayes RB
    Carcinogenesis; 2007 Sep; 28(9):1965-70. PubMed ID: 17615257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
    Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
    Brenner H; Hoffmeister M; Arndt V; Stegmaier C; Altenhofen L; Haug U
    J Natl Cancer Inst; 2010 Jan; 102(2):89-95. PubMed ID: 20042716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.